# ABRIDGE: Low Molecular Weight Heparin in Bridging Patients After Mechanical Valve Replacement

> **NCT00298285** · PHASE4 · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 100 (—)

## Conditions studied

- Mechanical Valve Replacement
- Warfarin Therapy

## Interventions

- **DRUG:** enoxaparin

## Key facts

- **NCT ID:** NCT00298285
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2006-10
- **Target enrollment:** 100 (—)
- **Last updated:** 2007-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00298285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00298285, "ABRIDGE: Low Molecular Weight Heparin in Bridging Patients After Mechanical Valve Replacement". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00298285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*